• 1
    Glenner, G. G. and Wong, C. W. ( 1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885890.
  • 2
    Haass, C. and Selkoe, D. J. ( 1993) Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide. Cell 75, 10391042.
  • 3
    De Strooper, B. and Annaert, W. ( 2000) Proteolytic processing and cell biological functions of the amyloid precursor protein. J. Cell. Sci. 113 ( Pt 11), 18571870.
  • 4
    De Strooper, B. ( 2003) Aph-1, Pen-2, and Nicastrin with Presenilin generate an active gamma-Secretase complex. Neuron 38, 912.
  • 5
    Tamaoka, A., Sawamura, N., Fukushima, T., Shoji, S., Matsubara, E., et al. ( 1997) Amyloid beta protein 42(43) in cerebrospinal fluid of patients with Alzheimer's disease. J. Neurol. Sci. 148, 4145.
  • 6
    Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., et al. ( 1992) Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 359, 322325.
  • 7
    Pearson, H. A. and Peers, C. ( 2006) Physiological roles for amyloid beta peptides. J Physiol 575, 510.
  • 8
    Puzzo, D., Privitera, L., Leznik, E., Fa, M., Staniszewski, A., et al. ( 2008) Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus. J. Neurosci. 28, 1453714545.
  • 9
    Puzzo, D., Privitera, L., Fa, M., Staniszewski, A., Hashimoto, G., etal. ( 2011) Endogenous amyloid-beta is necessary for hippocampal synaptic plasticity and memory. Ann. Neurol. 69, 819830.
  • 10
    Dudai, Y. ( 1986) Cyclic AMP and learning in Drosophila. Adv. Cyclic Nucleotide Protein Phosphorylation Res. 20, 343361.
  • 11
    Morimoto, B. H. and Koshland, D. E.Jr. ( 1991) Identification of cyclic AMP as the response regulator for neurosecretory potentiation: a memory model system. Proc. Natl. Acad. Sci. USA 88, 1083510839.
  • 12
    Barad, M., Bourtchouladze, R., Winder, D. G., Golan, H., and Kandel, E. ( 1998) Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory. Proc. Natl. Acad. Sci. USA 95, 1502015025.
  • 13
    Bourtchouladze, R., Lidge, R., Catapano, R., Stanley, J., Gossweiler, S., et al. ( 2003) A mouse model of Rubinstein-Taybi syndrome: defective long-term memory is ameliorated by inhibitors of phosphodiesterase 4. Proc. Natl. Acad. Sci. USA 100, 1051810522.
  • 14
    Li, Y. F., Cheng, Y. F., Huang, Y., Conti, M., Wilson, S. P., et al. ( 2011) Phosphodiesterase-4D knock-out and RNA interference-mediated knock-down enhance memory and increase hippocampal neurogenesis via increased cAMP signaling. J. Neurosci. 31, 172183.
  • 15
    Yamamoto-Sasaki, M., Ozawa, H., Saito, T., Rosler, M., and Riederer, P. ( 1999) Impaired phosphorylation of cyclic AMP response element binding protein in the hippocampus of dementia of the Alzheimer type. Brain Res. 824, 300303.
  • 16
    Liang, Z., Liu, F., Grundke-Iqbal, I., Iqbal, K., and Gong, C. X. ( 2007) Down-regulation of cAMP-dependent protein kinase by over-activated calpain in Alzheimer disease brain. J. Neurochem. 103, 24622470.
  • 17
    Gong, B., Vitolo, O. V., Trinchese, F., Liu, S., Shelanski, M., etal. ( 2004) Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment. J. Clin. Invest. 114, 16241634.
  • 18
    Reneerkens, O. A., Rutten, K., Steinbusch, H. W., Blokland, A., and Prickaerts, J. ( 2009) Selective phosphodiesterase inhibitors: a promising target for cognition enhancement. Psychopharmacology (Berl) 202, 419443.
  • 19
    Lee, R. K., Araki, W., and Wurtman, R. J. ( 1997) Stimulation of amyloid precursor protein synthesis by adrenergic receptors coupled to cAMP formation. Proc. Natl. Acad. Sci. USA 94, 54225426.
  • 20
    Marambaud, P., Chevallier, N., Ancolio, K., and Checler, F. ( 1998) Post-transcriptional contribution of a cAMP-dependent pathway to the formation of alpha- and beta/gamma-secretases-derived products of beta APP maturation in human cells expressing wild-type and Swedish mutated beta APP. Mol. Med. 4, 715723.
  • 21
    Su, Y., Ryder, J., and Ni, B. ( 2003) Inhibition of Abeta production and APP maturation by a specific PKA inhibitor. FEBS Lett. 546, 407410.
  • 22
    Canepa, E., Borghi, R., Vina, J., Traverso, N., Gambini, J., et al. ( 2011) Cholesterol and amyloid-beta: evidence for a cross-talk between astrocytes and neuronal cells. J. Alzheimers Dis. 25, 645653.
  • 23
    d'Abramo, C., Ricciarelli, R., Pronzato, M. A., and Davies, P. ( 2006) Troglitazone, a peroxisome proliferator-activated receptor-gamma agonist, decreases tau phosphorylation in CHOtau4R cells. J. Neurochem. 98, 10681077.
  • 24
    Chijiwa, T., Mishima, A., Hagiwara, M., Sano, M., Hayashi, K., et al. ( 1990) Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J. Biol. Chem. 265, 52675272.
  • 25
    Murray, A. J. ( 2008) Pharmacological PKA inhibition: all may not be what it seems. Sci. Signal 1, re4.
  • 26
    Lochner, A. and Moolman, J. A. ( 2006) The many faces of H89: a review. Cardiovasc. Drug Rev. 24, 261274.
  • 27
    Xu, H., Sweeney, D., Greengard, P., and Gandy, S. ( 1996) Metabolism of Alzheimer beta-amyloid precursor protein: regulation by protein kinase A in intact cells and in a cell-free system. Proc. Natl. Acad. Sci. USA 93, 40814084.
  • 28
    Marambaud, P., Ancolio, K., Alves da Costa, C., and Checler, F. ( 1999) Effect of protein kinase A inhibitors on the production of Abeta40 and Abeta42 by human cells expressing normal and Alzheimer's disease-linked mutated betaAPP and presenilin 1. Br. J. Pharmacol. 126, 11861190.
  • 29
    Rochais, F., Vandecasteele, G., Lefebvre, F., Lugnier, C., Lum, H., et al. ( 2004) Negative feedback exerted by cAMP-dependent protein kinase and cAMP phosphodiesterase on subsarcolemmal cAMP signals in intact cardiac myocytes: an in vivo study using adenovirus-mediated expression of CNG channels. J. Biol. Chem. 279, 5209552105.
  • 30
    Kwan, E. P., Xie, L., Sheu, L., Ohtsuka, T., and Gaisano, H. Y. ( 2007) Interaction between Munc13-1 and RIM is critical for glucagon-like peptide-1 mediated rescue of exocytotic defects in Munc13-1 deficient pancreatic beta-cells. Diabetes 56, 25792588.
  • 31
    Rogers, R. C. and Hermann, G. E. ( 2012) Tumor necrosis factor activation of vagal afferent terminal calcium is blocked by cannabinoids. J. Neurosci. 32, 52375241.
  • 32
    Maillet, M., Robert, S. J., Cacquevel, M., Gastineau, M., Vivien, D., et al. ( 2003) Crosstalk between Rap1 and Rac regulates secretion of sAPPalpha. Nat. Cell. Biol. 5, 633639.
  • 33
    Furukawa, K., Sopher, B. L., Rydel, R. E., Begley, J. G., Pham, D. G., et al. ( 1996) Increased activity-regulating and neuroprotective efficacy of alpha-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain. J. Neurochem. 67, 18821896.
  • 34
    Meziane, H., Dodart, J. C., Mathis, C., Little, S., Clemens, J., et al. ( 1998) Memory-enhancing effects of secreted forms of the beta-amyloid precursor protein in normal and amnestic mice. Proc. Natl. Acad. Sci. USA 95, 1268312688.
  • 35
    Taylor, C. J., Ireland, D. R., Ballagh, I., Bourne, K., Marechal, N. M., et al. ( 2008) Endogenous secreted amyloid precursor protein-alpha regulates hippocampal NMDA receptor function, long-term potentiation and spatial memory. Neurobiol. Dis. 31, 250260.
  • 36
    Plant, L. D., Boyle, J. P., Smith, I. F., Peers, C., and Pearson, H. A. ( 2003) The production of amyloid beta peptide is a critical requirement for the viability of central neurons. J. Neurosci. 23, 55315535.
  • 37
    Zou, K., Kim, D., Kakio, A., Byun, K., Gong, J. S., et al. ( 2003) Amyloid beta-protein (Abeta)1-40 protects neurons from damage induced by Abeta1-42 in culture and in rat brain. J. Neurochem. 87, 609619.
  • 38
    Sevalle, J., Amoyel, A., Robert, P., Fournie-Zaluski, M. C., Roques, B., et al. ( 2009) Aminopeptidase A contributes to the N-terminal truncation of amyloid beta-peptide. J. Neurochem. 109, 248256.
  • 39
    Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., et al. ( 1998) Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. USA 95, 64486453.
  • 40
    Cleary, J. P., Walsh, D. M., Hofmeister, J. J., Shankar, G. M., Kuskowski, M. A., et al. ( 2005) Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat. Neurosci. 8, 7984.
  • 41
    Haass, C. and Selkoe, D. J. ( 2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat. Rev. Mol. Cell. Biol. 8, 101112.
  • 42
    Vitolo, O. V., Sant'Angelo, A., Costanzo, V., Battaglia, F., Arancio, O., et al. ( 2002) Amyloid beta-peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling. Proc. Natl. Acad. Sci. USA 99, 1321713221.
  • 43
    Ramos, B. P., Birnbaum, S. G., Lindenmayer, I., Newton, S. S., Duman, R. S., et al. ( 2003) Dysregulation of protein kinase a signaling in the aged prefrontal cortex: new strategy for treating age-related cognitive decline. Neuron 40, 835845.
  • 44
    Giorgi, M., Modica, A., Pompili, A., Pacitti, C., and Gasbarri, A. ( 2004) The induction of cyclic nucleotide phosphodiesterase 4 gene (PDE4D) impairs memory in a water maze task. Behav. Brain Res. 154, 99106.